Our Company
Prazer Therapeutics is a company committed to fostering a disease-free society
by pioneering innovative drug development technologies to tackle intractable diseases.
-
No. of EMPOLYEE
25 13 Ph.D.
-
FOUNDING YEAR
2019
-
LOCATION
Seoul, Korea
Vision & Mission
We strive to fulfill our mission through rational molecular drug design and next-generation protein degradation technologies, leveraging an innovative drug development platform.
Our vision is to make the untreatable diseases treatable,
transforming intractable diseases into manageable conditions and providing new hope to humanity.
Our goal is to address current unmet medical needs through cutting-edge platform technologies.
We are working collaboratively with all our partners to create a healthy, disease-free society.
-
Technology
A New Paradigm in Molecular Drug DesignA novel targeted protein degradation platform that
enables drug development for previously
undruggable targets.- A new business model that allows for co-development
with global pharmaceutical companies from the early stages of development.
- A new business model that allows for co-development
-
Target
Targets with significant unmet medical needs
that are difficult to address with existing drugs.Neurological and refractory inflammatory diseases,
where current treatment options are limited.- Diseases that require continuous administration and have large market potential.
- A treatment strategy optimized to eliminate the accumulation of pathological proteins.
-
Team
A leading team of experts in
drug discovery and development.Specialists in molecular drug design,
efficacy evaluation, MOA analysis, and animal models- A synergistic network, integrating basic medical sciences,
pharmacy, and veterinary medicine.
- A synergistic network, integrating basic medical sciences,
Certification
| Certificate | Initial Registration Date |
|---|---|
| SME Confirmation Certificate | Since 2019.11.07 |
| Corporate Research Institute Accreditation (2023) | Since 2020.03.23 |
| Tomorrow Filling Deduction (Youth Employment Incentive) | Since 2020.05.21 |
| Venture Business Certification (2024.12.26) | Since 2021.12.27 |
| Promising Small Enterprise Certificate | Since 2023.05.01 |
| Family-Friendly Certification (2023.11.30) | Since 2023.12.01 |
| Award | Date |
|---|---|
| Selected as the Winner of Seoul BMS Innovation Square Challenge | 2022.11 |
| Money Today – 8th Korea Business Awards 2022, R&D Innovation Category | 2023.01 |
| Winner of The 5th Boehringer Ingelheim Innovation Prize (by Prazer) | 2023.10 |
-
DownloadChemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease
Targeted protein degradation (TPD) provides unique advantages over gene knockdown in that it can induce selective degradation of disease-associated proteins attributed to pathological mutations or aberrant post-translational modifications(PTMs). Herein, we report a protein degrader, PRZ-18002, that selectively binds to an active form of p38 MAPK. PRZ-18002induces degradation of phosphorylated p38 MAPK (p-p38) and a phosphomimetic mutant of p38 MAPK in a proteasome-dependent manner. Given that the activation of p38 MAPK plays pivotal roles in the pathophysiology of Alzheimer’s disease (AD), selective -
DownloadTransforming the future of targeted protein degradation with the SPiDEM platform
South Korean biotech Prazer Therapeutics is creating and validating a breakthrough drug discovery and development platform based on targeted protein degradation (TPD) technology to tackle previously undruggable targets in oncology, neuroscience and other therapeutic areas that are not readily addressable with existing TPD approaches.
CI Introduction
The name "Prazer" is a blend of “protein” and “eraser”, reflecting our commitment to eliminating disease-associated proteins. Our mission and identity are rooted in developing treatments for neurodegenerative diseases and drug-resistant cancers, addressing areas of high unmet medical needs.
Logo Type
Color System
PRAZER GREEN
#8BD8BDR 139 G 216 B 189
C 49 M 0 Y 36 K 0
PRAZER BLUE
#243665R 36 G 54 B 101
C 95 M 90 Y 43 K 9